Company Bioscience Neutraceuticals, Inc. Other OTC
Equities
DEVV
US09075H2022
Employment Services
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Liang Chen
CEO | Chief Executive Officer | 35 | 17-05-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Liang Chen
CEO | Chief Executive Officer | 35 | 17-05-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,042,516 | 8,042,516 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Bioscience Neutraceuticals, Inc.
500 North Michigan Avenue Suite 600
60611, Chicago
+
Sector
1st Jan change | Capi. | |
---|---|---|
+14.15% | 8.45B | |
-13.14% | 1.9B | |
-1.87% | 1.02B | |
-37.84% | 858M | |
-5.23% | 796M | |
-0.07% | 672M | |
+7.78% | 234M | |
-3.17% | 170M | |
-56.33% | 157M |